Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
34
Frequently Asked Questions
What is Market Cap of Predictive Oncology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Predictive Oncology Inc market cap is $6.13M.
What is the 52-week high for Predictive Oncology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Predictive Oncology Inc 52 week high is $7.12 as of April 16, 2024.
What is the 52-week low for Predictive Oncology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Predictive Oncology Inc 52 week low is $1.46 as of April 16, 2024.
What is Predictive Oncology Inc stock price today?
Predictive Oncology Inc stock price today is $1.51.
What was Predictive Oncology Inc stock price yesterday?
Predictive Oncology Inc stock price yesterday was $1.76.
What is the PE ratio of Predictive Oncology Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Predictive Oncology Inc’s P/E ratio is -0.43.
What is the Price-to-Book ratio of Predictive Oncology Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Predictive Oncology Inc P/B ratio is 0.7417.
What is Predictive Oncology Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Predictive Oncology Inc's EBITDA is -0.57.
What is the 50-day moving average of Predictive Oncology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Predictive Oncology Inc 50-day moving average is $2.71.
How many employess does Predictive Oncology Inc has?